Company profile for Mainz BioMed

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Clinical laboratory tests save costs and lives by enabling early detection and prevention of disease. Patients with cancers and other conditions are living longer and enjoying better health because of medical revolutions in diagnostic technology. At its center are genetic and genomic tests that identify the unique genetic profile of individual patients or their disease and allow physicians to tailor treatment to those un...
Clinical laboratory tests save costs and lives by enabling early detection and prevention of disease. Patients with cancers and other conditions are living longer and enjoying better health because of medical revolutions in diagnostic technology. At its center are genetic and genomic tests that identify the unique genetic profile of individual patients or their disease and allow physicians to tailor treatment to those unique characteristics. Mainz BioMed (NASDAQ: MYNZ) develops market-ready molecular genetic diagnostic solutions for life-threatening conditions.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Germany
Address
Address
Sirius Gutenberg Park Robert-Koch-Straße 50 55129, Mainz
Telephone
Telephone
+49 (0) 6131 / 55428-60
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

IPhEB Russia

Not Confirmed

envelop Contact Supplier

IPhEB Russia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2026/03/17/3257169/0/en/Quantum-Cyber-Aligns-Strategy-With-Trump-Administration-s-National-Cyber-Security-Framework-Targets-Acquisitions-in-Quantum-and-Cyber-Defense-Sectors.html

GLOBENEWSWIRE
17 Mar 2026

https://www.globenewswire.com/news-release/2026/03/13/3255389/0/en/Quantum-Cyber-f-k-a-Mainz-Biomed-Announces-Stock-Ticker-Symbol-Change-to-NASDAQ-QUCY.html

GLOBENEWSWIRE
13 Mar 2026

https://www.globenewswire.com/news-release/2026/03/11/3253651/0/en/Mainz-Biomed-Announces-Appointment-of-Robert-Liscouski-as-Chairman-of-the-Board-of-Directors.html

GLOBENEWSWIRE
11 Mar 2026

https://www.globenewswire.com/news-release/2026/02/24/3243437/0/en/Mainz-Biomed-to-Present-at-the-Pancreatic-Cancer-Session-at-Digestive-Disease-Week-Demonstrating-Effectiveness-of-mRNA-Biomarkers-in-Blood-Samples.html

GLOBENEWSWIRE
24 Feb 2026

https://www.globenewswire.com/news-release/2026/02/17/3239147/0/en/Mainz-Biomed-Announces-6-0-USD-Million-Private-Placement-and-Strategic-Update.html

GLOBENEWSWIRE
17 Feb 2026

https://www.globenewswire.com/news-release/2026/01/14/3218765/0/en/Mainz-Biomed-to-Present-Results-of-Pancreatic-Cancer-Verification-Study-at-AACR-2026-Annual-Meeting.html

GLOBENEWSWIRE
14 Jan 2026

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty